The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of cetuximab after immunotherapy (IO) in advanced cutaneous squamous cell carcinoma (CSCC).
 
Julian Andres Marin-Acevedo
No Relationships to Disclose
 
Bethany Withycombe
Consulting or Advisory Role - Dedham Group
 
Youngchul Kim
No Relationships to Disclose
 
Zeynep Eroglu
Consulting or Advisory Role - Elsevier; Genentech/Roche; Natera; Novartis; OncoSec; Regeneron; Sun Pharma
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Joseph Markowitz
Stock and Other Ownership Interests - Aflac; Amdocs; Consolidated Edison; CVS; Intel
Honoraria - Springer
Consulting or Advisory Role - Array Biopharma; Idera; Newlink Genetics
Research Funding - Genoptix (Inst); Idera (Inst); Jackson Laboratory for Genomic Medicine (Inst); Macrogenics (Inst); Merck (Inst); Morphogenesis (Inst); Reata Pharmaceuticals (Inst)
Other Relationship - Springer
 
Andrew S. Brohl
Consulting or Advisory Role - Bayer; Deciphera; EMD Serono
Expert Testimony - GlaxoSmithKline (I)
 
Ahmad A. Tarhini
Consulting or Advisory Role - Array BioPharma; BioNTech; Bristol-Myers Squibb; Genentech/Roche; Immunocore; Merck; Novartis; Partner Therapeutics; Pfizer/EMD Serono; Sanofi/Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); OncoSec (Inst); Prometheus (Inst); Sanofi/Regeneron (Inst)
 
Kenneth Yee Tsai
Stock and Other Ownership Interests - Dimerix; NFlection Therapeutics
Consulting or Advisory Role - EMD Serono; NFLection Therapeutics; Sun Pharma
Research Funding - FORMA Therapeutics
Patents, Royalties, Other Intellectual Property - NFlection Therapeutics and Moffitt Cancer Center, John Kincaid, Kavita Sarin, Kenneth Y. Tsai, ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF SKIN CANCERS, 046776-523P01US, 11/20/2019; UCSB, Samir Mitragotri, Byeong Hee Hwang, Nishit Doshi, Kenneth Tsai, Russell M. Lebovitz. COMPOSITIONS FOR SOLUBILIZING CELLS AND/OR TISSUE, United States, 13/432,978, 3/28/2012.
 
Nikhil I. Khushalani
Stock and Other Ownership Interests - Amarin Corporation; Asensus Surgical; Bellicum Pharmaceuticals; Mazor Robotics
Honoraria - Sanofi
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Immunocore; Incyte; Iovance Biotherapeutics; Jounce Therapeutics; Merck; NCCN/Pfizer; Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst); Replimune (Inst)